Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Histone Deacetylases | 68 | 2023 | 198 | 13.400 |
Why?
|
Histone Deacetylase Inhibitors | 33 | 2023 | 200 | 7.600 |
Why?
|
Cardiomegaly | 33 | 2020 | 168 | 6.560 |
Why?
|
Myocytes, Cardiac | 36 | 2022 | 472 | 5.460 |
Why?
|
Myocardium | 35 | 2023 | 970 | 4.860 |
Why?
|
Heart Failure | 29 | 2023 | 1969 | 4.550 |
Why?
|
Fibrosis | 19 | 2023 | 483 | 3.370 |
Why?
|
Fibroblasts | 24 | 2023 | 842 | 3.290 |
Why?
|
Heart | 17 | 2022 | 631 | 3.250 |
Why?
|
Ventricular Remodeling | 13 | 2023 | 229 | 3.040 |
Why?
|
Protein Kinase C | 18 | 2015 | 297 | 2.710 |
Why?
|
Myofibrils | 8 | 2023 | 50 | 2.220 |
Why?
|
Transcription Factors | 27 | 2021 | 1570 | 2.170 |
Why?
|
Epigenesis, Genetic | 12 | 2023 | 539 | 2.070 |
Why?
|
Myofibroblasts | 5 | 2023 | 120 | 1.940 |
Why?
|
Hypertrophy, Right Ventricular | 4 | 2021 | 146 | 1.860 |
Why?
|
Animals | 128 | 2023 | 33381 | 1.860 |
Why?
|
Rats | 49 | 2022 | 5392 | 1.840 |
Why?
|
Adipocytes | 3 | 2023 | 199 | 1.720 |
Why?
|
Extracellular Matrix | 6 | 2023 | 446 | 1.690 |
Why?
|
Signal Transduction | 47 | 2022 | 4709 | 1.640 |
Why?
|
Gene Expression Regulation | 32 | 2022 | 2445 | 1.560 |
Why?
|
Nuclear Proteins | 8 | 2019 | 597 | 1.550 |
Why?
|
Rats, Sprague-Dawley | 31 | 2021 | 2478 | 1.480 |
Why?
|
Dual-Specificity Phosphatases | 3 | 2021 | 10 | 1.430 |
Why?
|
Chromatin | 8 | 2021 | 441 | 1.420 |
Why?
|
Protein Processing, Post-Translational | 8 | 2023 | 408 | 1.400 |
Why?
|
Cells, Cultured | 35 | 2023 | 4077 | 1.390 |
Why?
|
Hypertension, Pulmonary | 11 | 2021 | 1794 | 1.350 |
Why?
|
Mice | 58 | 2023 | 15520 | 1.310 |
Why?
|
Histones | 12 | 2020 | 552 | 1.290 |
Why?
|
Heart Ventricles | 13 | 2022 | 727 | 1.270 |
Why?
|
Angiotensin II | 5 | 2021 | 107 | 1.230 |
Why?
|
Heart-Assist Devices | 2 | 2022 | 485 | 1.090 |
Why?
|
Gene Expression Regulation, Enzymologic | 7 | 2019 | 290 | 1.070 |
Why?
|
Phosphorylation | 26 | 2023 | 1633 | 1.050 |
Why?
|
Lysine | 6 | 2022 | 248 | 1.050 |
Why?
|
Hydroxamic Acids | 6 | 2018 | 80 | 1.030 |
Why?
|
Vascular Remodeling | 3 | 2021 | 152 | 1.020 |
Why?
|
Acetylation | 15 | 2020 | 217 | 1.000 |
Why?
|
Myocytes, Smooth Muscle | 5 | 2021 | 236 | 0.950 |
Why?
|
DNA-Binding Proteins | 27 | 2005 | 1346 | 0.950 |
Why?
|
Catecholamines | 1 | 2023 | 100 | 0.920 |
Why?
|
Sarcomeres | 3 | 2022 | 91 | 0.920 |
Why?
|
Heart Diseases | 4 | 2021 | 341 | 0.890 |
Why?
|
Thermogenesis | 2 | 2023 | 43 | 0.880 |
Why?
|
Muscle, Skeletal | 9 | 2023 | 1515 | 0.870 |
Why?
|
Rejuvenation | 1 | 2022 | 14 | 0.870 |
Why?
|
Humans | 94 | 2023 | 118972 | 0.860 |
Why?
|
Adipose Tissue, Brown | 2 | 2023 | 71 | 0.850 |
Why?
|
Aortic Valve Insufficiency | 1 | 2022 | 42 | 0.830 |
Why?
|
Cell Proliferation | 5 | 2021 | 2275 | 0.820 |
Why?
|
Assisted Circulation | 1 | 2021 | 24 | 0.820 |
Why?
|
Animals, Newborn | 14 | 2017 | 806 | 0.790 |
Why?
|
Heart Murmurs | 1 | 2021 | 12 | 0.790 |
Why?
|
Cell Nucleus | 13 | 2015 | 580 | 0.780 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2022 | 374 | 0.770 |
Why?
|
Disease Models, Animal | 20 | 2022 | 3730 | 0.750 |
Why?
|
Epigenomics | 3 | 2021 | 107 | 0.750 |
Why?
|
Arteries | 1 | 2022 | 250 | 0.750 |
Why?
|
Aortic Diseases | 1 | 2021 | 94 | 0.750 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2020 | 57 | 0.740 |
Why?
|
Histone Deacetylase 6 | 6 | 2022 | 19 | 0.720 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2017 | 394 | 0.720 |
Why?
|
Muscle Proteins | 5 | 2015 | 219 | 0.670 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 10 | 2006 | 175 | 0.670 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2019 | 83 | 0.650 |
Why?
|
Pulmonary Artery | 4 | 2021 | 1063 | 0.650 |
Why?
|
MEF2 Transcription Factors | 15 | 2020 | 57 | 0.650 |
Why?
|
T-Lymphocytes | 6 | 2022 | 1774 | 0.650 |
Why?
|
I-kappa B Proteins | 8 | 2000 | 80 | 0.640 |
Why?
|
Calcineurin | 11 | 2008 | 95 | 0.640 |
Why?
|
Drug Discovery | 2 | 2016 | 124 | 0.630 |
Why?
|
Immunotherapy | 1 | 2022 | 493 | 0.630 |
Why?
|
Oxidative Stress | 3 | 2019 | 1178 | 0.620 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2019 | 404 | 0.610 |
Why?
|
High-Throughput Screening Assays | 2 | 2016 | 122 | 0.610 |
Why?
|
Karyopherins | 2 | 2009 | 17 | 0.600 |
Why?
|
Models, Biological | 15 | 2022 | 1715 | 0.590 |
Why?
|
Repressor Proteins | 10 | 2019 | 377 | 0.590 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2017 | 160 | 0.580 |
Why?
|
Muscle, Smooth, Vascular | 5 | 2021 | 454 | 0.580 |
Why?
|
Mice, Inbred C57BL | 18 | 2022 | 4908 | 0.560 |
Why?
|
Mice, Knockout | 10 | 2022 | 2680 | 0.560 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 4 | 2009 | 195 | 0.560 |
Why?
|
Protein Binding | 13 | 2019 | 1975 | 0.560 |
Why?
|
Fatty Liver | 1 | 2018 | 253 | 0.540 |
Why?
|
Histone Acetyltransferases | 2 | 2014 | 53 | 0.540 |
Why?
|
Alkaline Phosphatase | 2 | 2017 | 157 | 0.540 |
Why?
|
Transforming Growth Factor beta | 6 | 2021 | 462 | 0.530 |
Why?
|
NF-kappa B | 10 | 2017 | 670 | 0.520 |
Why?
|
Microtubules | 1 | 2017 | 241 | 0.520 |
Why?
|
Male | 47 | 2022 | 57801 | 0.510 |
Why?
|
Blood Pressure | 5 | 2020 | 1664 | 0.510 |
Why?
|
Sumoylation | 1 | 2014 | 16 | 0.510 |
Why?
|
Transcription, Genetic | 15 | 2014 | 1323 | 0.510 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2014 | 36 | 0.510 |
Why?
|
Carbazoles | 1 | 2015 | 80 | 0.510 |
Why?
|
Receptors, Endothelin | 1 | 2014 | 49 | 0.500 |
Why?
|
SUMO-1 Protein | 1 | 2014 | 21 | 0.500 |
Why?
|
Enzyme Inhibitors | 5 | 2016 | 827 | 0.500 |
Why?
|
Myogenic Regulatory Factors | 13 | 2009 | 51 | 0.490 |
Why?
|
Cardiotonic Agents | 2 | 2014 | 127 | 0.490 |
Why?
|
Active Transport, Cell Nucleus | 9 | 2010 | 113 | 0.480 |
Why?
|
MicroRNAs | 4 | 2021 | 637 | 0.480 |
Why?
|
Pyrroles | 1 | 2015 | 191 | 0.480 |
Why?
|
Carrier Proteins | 4 | 2013 | 726 | 0.470 |
Why?
|
Muscular Atrophy | 1 | 2014 | 80 | 0.470 |
Why?
|
YY1 Transcription Factor | 2 | 2015 | 27 | 0.460 |
Why?
|
Calcium | 4 | 2023 | 1169 | 0.440 |
Why?
|
Myocardial Contraction | 5 | 2023 | 339 | 0.430 |
Why?
|
Isoenzymes | 7 | 2017 | 297 | 0.420 |
Why?
|
Stroke Volume | 5 | 2023 | 512 | 0.400 |
Why?
|
Immunoblotting | 5 | 2014 | 307 | 0.400 |
Why?
|
Troponin I | 2 | 2023 | 83 | 0.400 |
Why?
|
Membrane Glycoproteins | 2 | 2005 | 446 | 0.390 |
Why?
|
Connectin | 2 | 2022 | 26 | 0.380 |
Why?
|
RNA Polymerase II | 3 | 2019 | 282 | 0.380 |
Why?
|
Stem Cell Transplantation | 2 | 2021 | 153 | 0.380 |
Why?
|
Myosin Heavy Chains | 4 | 2010 | 192 | 0.370 |
Why?
|
Nuclear Localization Signals | 1 | 2010 | 14 | 0.370 |
Why?
|
Benzamides | 3 | 2019 | 176 | 0.370 |
Why?
|
Enhancer Elements, Genetic | 4 | 2021 | 152 | 0.370 |
Why?
|
Cardiovascular Agents | 2 | 2011 | 126 | 0.370 |
Why?
|
HEK293 Cells | 4 | 2019 | 625 | 0.370 |
Why?
|
Induced Pluripotent Stem Cells | 3 | 2021 | 185 | 0.360 |
Why?
|
Obesity | 3 | 2022 | 2746 | 0.360 |
Why?
|
RNA-Binding Proteins | 3 | 2021 | 371 | 0.350 |
Why?
|
Cell Line | 16 | 2021 | 2707 | 0.350 |
Why?
|
Protein Isoforms | 4 | 2013 | 345 | 0.340 |
Why?
|
Membrane Proteins | 1 | 2015 | 1055 | 0.340 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2010 | 490 | 0.330 |
Why?
|
Azepines | 3 | 2019 | 74 | 0.320 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 2174 | 0.320 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2022 | 154 | 0.320 |
Why?
|
Cardiomyopathies | 2 | 2023 | 299 | 0.310 |
Why?
|
Inflammation Mediators | 3 | 2021 | 502 | 0.310 |
Why?
|
Triazoles | 3 | 2019 | 134 | 0.300 |
Why?
|
Protein Kinase Inhibitors | 2 | 2011 | 811 | 0.300 |
Why?
|
Aortic Valve | 3 | 2022 | 401 | 0.300 |
Why?
|
TRPC Cation Channels | 1 | 2006 | 11 | 0.290 |
Why?
|
Ankyrins | 2 | 2005 | 7 | 0.280 |
Why?
|
COS Cells | 6 | 2010 | 184 | 0.280 |
Why?
|
Hydrogels | 3 | 2023 | 582 | 0.280 |
Why?
|
Cell Differentiation | 6 | 2021 | 1753 | 0.270 |
Why?
|
Phenotype | 7 | 2023 | 3003 | 0.270 |
Why?
|
GATA4 Transcription Factor | 4 | 2020 | 18 | 0.270 |
Why?
|
Small Molecule Libraries | 2 | 2016 | 80 | 0.270 |
Why?
|
RNA, Messenger | 9 | 2022 | 2657 | 0.270 |
Why?
|
Myocardial Infarction | 3 | 2021 | 968 | 0.270 |
Why?
|
Amino Acid Sequence | 11 | 2016 | 2071 | 0.260 |
Why?
|
Acylation | 2 | 2022 | 28 | 0.260 |
Why?
|
Protein Kinases | 2 | 2007 | 310 | 0.260 |
Why?
|
Cortical Bone | 2 | 2021 | 18 | 0.260 |
Why?
|
Calcium Signaling | 4 | 2015 | 219 | 0.260 |
Why?
|
Proteins | 4 | 2021 | 938 | 0.250 |
Why?
|
Aging | 1 | 2015 | 1670 | 0.250 |
Why?
|
Cardiac Output, Low | 1 | 2005 | 68 | 0.250 |
Why?
|
MAP Kinase Signaling System | 3 | 2021 | 292 | 0.250 |
Why?
|
Female | 24 | 2022 | 61564 | 0.250 |
Why?
|
3T3-L1 Cells | 2 | 2022 | 35 | 0.250 |
Why?
|
Estrogens | 2 | 2020 | 328 | 0.250 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2021 | 119 | 0.250 |
Why?
|
Hypoxia | 5 | 2013 | 963 | 0.240 |
Why?
|
Transcriptome | 5 | 2021 | 756 | 0.240 |
Why?
|
Sequence Analysis, RNA | 3 | 2021 | 409 | 0.240 |
Why?
|
Uncoupling Protein 1 | 1 | 2023 | 16 | 0.240 |
Why?
|
Mice, Transgenic | 12 | 2023 | 2025 | 0.240 |
Why?
|
Adaptation, Physiological | 4 | 2017 | 502 | 0.230 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2022 | 164 | 0.230 |
Why?
|
Hypertension | 2 | 2011 | 1203 | 0.230 |
Why?
|
Arrhythmias, Cardiac | 2 | 2017 | 277 | 0.230 |
Why?
|
Acute Kidney Injury | 2 | 2022 | 709 | 0.230 |
Why?
|
Genetic Therapy | 1 | 2005 | 267 | 0.230 |
Why?
|
Diet, High-Fat | 3 | 2022 | 247 | 0.230 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2013 | 982 | 0.220 |
Why?
|
Calcinosis | 2 | 2017 | 282 | 0.220 |
Why?
|
Valproic Acid | 2 | 2013 | 44 | 0.220 |
Why?
|
Stress, Physiological | 1 | 2006 | 415 | 0.220 |
Why?
|
Inflammation | 4 | 2017 | 2566 | 0.220 |
Why?
|
Endocardium | 1 | 2022 | 31 | 0.220 |
Why?
|
Autophagy | 2 | 2017 | 315 | 0.220 |
Why?
|
Metalloproteases | 1 | 2022 | 38 | 0.220 |
Why?
|
Hemodynamics | 2 | 2018 | 1003 | 0.210 |
Why?
|
Cellular Senescence | 1 | 2023 | 151 | 0.210 |
Why?
|
Adipose Tissue | 2 | 2023 | 606 | 0.210 |
Why?
|
Enzyme Activation | 6 | 2022 | 828 | 0.210 |
Why?
|
Macrophage Activation | 2 | 2021 | 168 | 0.210 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2022 | 41 | 0.210 |
Why?
|
Cell Physiological Phenomena | 1 | 2002 | 23 | 0.210 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2023 | 80 | 0.210 |
Why?
|
Matrix Metalloproteinases, Secreted | 1 | 2021 | 10 | 0.210 |
Why?
|
NFATC Transcription Factors | 6 | 2006 | 82 | 0.210 |
Why?
|
Long Term Adverse Effects | 1 | 2021 | 10 | 0.210 |
Why?
|
ADAMTS4 Protein | 1 | 2021 | 15 | 0.210 |
Why?
|
Thiazepines | 1 | 2021 | 5 | 0.210 |
Why?
|
Immunohistochemistry | 4 | 2021 | 1691 | 0.210 |
Why?
|
Polymerase Chain Reaction | 3 | 2013 | 1012 | 0.200 |
Why?
|
Cell Cycle Proteins | 2 | 2016 | 565 | 0.200 |
Why?
|
Ryanodine Receptor Calcium Release Channel | 1 | 2021 | 59 | 0.200 |
Why?
|
Paracrine Communication | 1 | 2021 | 57 | 0.200 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2021 | 105 | 0.200 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2000 | 70 | 0.190 |
Why?
|
Adenylate Kinase | 3 | 2013 | 29 | 0.190 |
Why?
|
Naphthyridines | 2 | 2010 | 16 | 0.190 |
Why?
|
Vasoconstrictor Agents | 1 | 2021 | 122 | 0.190 |
Why?
|
Serine | 5 | 2006 | 138 | 0.190 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2011 | 180 | 0.190 |
Why?
|
Exosomes | 1 | 2021 | 92 | 0.190 |
Why?
|
Transcriptional Activation | 6 | 2013 | 348 | 0.190 |
Why?
|
Leptin | 1 | 2022 | 231 | 0.190 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2020 | 59 | 0.190 |
Why?
|
RNA Interference | 2 | 2013 | 460 | 0.180 |
Why?
|
Microscopy, Fluorescence | 3 | 2009 | 412 | 0.180 |
Why?
|
Catalytic Domain | 3 | 2015 | 206 | 0.180 |
Why?
|
Immunoglobulins | 1 | 2000 | 154 | 0.180 |
Why?
|
Aminopyridines | 2 | 2010 | 85 | 0.180 |
Why?
|
Protein Transport | 3 | 2009 | 412 | 0.180 |
Why?
|
Macrophages | 3 | 2021 | 1324 | 0.180 |
Why?
|
Succinic Acid | 1 | 2019 | 46 | 0.180 |
Why?
|
Histone Deacetylase 1 | 2 | 2017 | 16 | 0.180 |
Why?
|
Diastole | 1 | 2020 | 145 | 0.180 |
Why?
|
Energy Metabolism | 3 | 2022 | 767 | 0.180 |
Why?
|
Pyrimidines | 2 | 2013 | 382 | 0.180 |
Why?
|
Molecular Sequence Data | 12 | 2011 | 2871 | 0.170 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 246 | 0.170 |
Why?
|
Oxadiazoles | 1 | 2019 | 32 | 0.170 |
Why?
|
Ventricular Function | 1 | 2019 | 60 | 0.170 |
Why?
|
Biomimetics | 1 | 2019 | 38 | 0.170 |
Why?
|
Serum | 1 | 2019 | 63 | 0.170 |
Why?
|
Phosphodiesterase 3 Inhibitors | 1 | 2019 | 13 | 0.170 |
Why?
|
Wound Healing | 1 | 2021 | 270 | 0.170 |
Why?
|
Cardio-Renal Syndrome | 1 | 2019 | 13 | 0.170 |
Why?
|
Heart Failure, Diastolic | 1 | 2019 | 21 | 0.170 |
Why?
|
Proteomics | 2 | 2022 | 876 | 0.170 |
Why?
|
Receptor Cross-Talk | 1 | 2018 | 22 | 0.170 |
Why?
|
Mitochondria, Heart | 1 | 2019 | 76 | 0.170 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2021 | 814 | 0.170 |
Why?
|
Histone Code | 1 | 2018 | 29 | 0.170 |
Why?
|
Cell Culture Techniques | 1 | 2021 | 356 | 0.160 |
Why?
|
3' Untranslated Regions | 2 | 2016 | 142 | 0.160 |
Why?
|
Cell Adhesion Molecules | 1 | 2019 | 180 | 0.160 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 285 | 0.160 |
Why?
|
Biopsy | 1 | 2022 | 1079 | 0.160 |
Why?
|
Gold | 1 | 2019 | 102 | 0.160 |
Why?
|
Adipose Tissue, White | 1 | 2018 | 35 | 0.160 |
Why?
|
Metal Nanoparticles | 1 | 2019 | 73 | 0.160 |
Why?
|
RNA, Small Interfering | 3 | 2011 | 564 | 0.160 |
Why?
|
Synovial Membrane | 2 | 2016 | 71 | 0.160 |
Why?
|
Case-Control Studies | 3 | 2021 | 3171 | 0.160 |
Why?
|
Myocardial Ischemia | 1 | 2019 | 251 | 0.160 |
Why?
|
Amides | 2 | 2009 | 86 | 0.160 |
Why?
|
Protein Domains | 1 | 2019 | 212 | 0.160 |
Why?
|
Middle Aged | 10 | 2021 | 27617 | 0.160 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2018 | 93 | 0.160 |
Why?
|
Mitogen-Activated Protein Kinase 14 | 1 | 2017 | 6 | 0.160 |
Why?
|
Mitochondrial Proteins | 1 | 2019 | 226 | 0.160 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 4 | 2008 | 159 | 0.160 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2017 | 1171 | 0.160 |
Why?
|
Myosins | 1 | 2018 | 130 | 0.150 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 468 | 0.150 |
Why?
|
Adenoviridae | 2 | 2011 | 191 | 0.150 |
Why?
|
Feedback, Physiological | 1 | 2017 | 75 | 0.150 |
Why?
|
Calcineurin Inhibitors | 3 | 2004 | 61 | 0.150 |
Why?
|
NAV1.5 Voltage-Gated Sodium Channel | 1 | 2017 | 11 | 0.150 |
Why?
|
Structure-Activity Relationship | 5 | 2011 | 522 | 0.150 |
Why?
|
Transcatheter Aortic Valve Replacement | 1 | 2019 | 151 | 0.150 |
Why?
|
Human T-lymphotropic virus 1 | 2 | 1996 | 23 | 0.150 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2017 | 155 | 0.150 |
Why?
|
Arthritis, Rheumatoid | 2 | 2016 | 989 | 0.150 |
Why?
|
Tubulin | 2 | 2015 | 122 | 0.150 |
Why?
|
Tissue Scaffolds | 1 | 2019 | 184 | 0.150 |
Why?
|
Lymphocyte Activation | 2 | 2000 | 1067 | 0.150 |
Why?
|
Down-Regulation | 2 | 2016 | 627 | 0.150 |
Why?
|
Gap Junctions | 1 | 2017 | 58 | 0.150 |
Why?
|
Stem Cells | 1 | 2021 | 559 | 0.150 |
Why?
|
Metabolic Syndrome | 1 | 2021 | 394 | 0.140 |
Why?
|
CapZ Actin Capping Protein | 1 | 2016 | 2 | 0.140 |
Why?
|
Tryptophan Hydroxylase | 1 | 2016 | 52 | 0.140 |
Why?
|
Synoviocytes | 1 | 2016 | 10 | 0.140 |
Why?
|
14-3-3 Proteins | 2 | 2010 | 13 | 0.140 |
Why?
|
Gene Knockdown Techniques | 1 | 2017 | 311 | 0.140 |
Why?
|
Reactive Oxygen Species | 1 | 2019 | 576 | 0.140 |
Why?
|
Cardiovascular Diseases | 3 | 2021 | 1798 | 0.140 |
Why?
|
Cell Movement | 4 | 2015 | 896 | 0.140 |
Why?
|
Transcription Elongation, Genetic | 1 | 2016 | 20 | 0.140 |
Why?
|
Gene Products, tat | 1 | 1996 | 21 | 0.140 |
Why?
|
Transcription Initiation Site | 1 | 2016 | 42 | 0.140 |
Why?
|
RNA, Long Noncoding | 1 | 2018 | 161 | 0.140 |
Why?
|
Pyridines | 2 | 2012 | 440 | 0.140 |
Why?
|
Ventricular Function, Left | 2 | 2022 | 468 | 0.140 |
Why?
|
Serum Response Factor | 1 | 2016 | 31 | 0.140 |
Why?
|
Cardiomyopathy, Dilated | 3 | 2015 | 344 | 0.140 |
Why?
|
Molecular Imaging | 1 | 2016 | 54 | 0.140 |
Why?
|
Binding Sites | 6 | 2008 | 1224 | 0.140 |
Why?
|
Hypertrophy | 3 | 2023 | 121 | 0.140 |
Why?
|
Cellular Reprogramming Techniques | 1 | 2015 | 12 | 0.140 |
Why?
|
Ischemia | 1 | 2019 | 374 | 0.130 |
Why?
|
Reproducibility of Results | 3 | 2019 | 2874 | 0.130 |
Why?
|
Cell Cycle | 2 | 2019 | 550 | 0.130 |
Why?
|
Positron-Emission Tomography | 1 | 2017 | 298 | 0.130 |
Why?
|
Ventricular Function, Right | 1 | 2017 | 257 | 0.130 |
Why?
|
Tissue Engineering | 1 | 2019 | 362 | 0.130 |
Why?
|
Interleukins | 1 | 2017 | 242 | 0.130 |
Why?
|
rho-Associated Kinases | 1 | 2015 | 84 | 0.130 |
Why?
|
PTEN Phosphohydrolase | 1 | 2016 | 143 | 0.130 |
Why?
|
Cellular Reprogramming | 1 | 2015 | 85 | 0.130 |
Why?
|
Chagas Cardiomyopathy | 1 | 2015 | 21 | 0.130 |
Why?
|
Osteogenesis | 1 | 2017 | 213 | 0.130 |
Why?
|
Promoter Regions, Genetic | 5 | 2016 | 1158 | 0.120 |
Why?
|
Endopeptidases | 1 | 2014 | 73 | 0.120 |
Why?
|
Transcription Factor CHOP | 1 | 2014 | 29 | 0.120 |
Why?
|
Biocatalysis | 1 | 2014 | 64 | 0.120 |
Why?
|
Positive Transcriptional Elongation Factor B | 1 | 2014 | 22 | 0.120 |
Why?
|
Superoxide Dismutase | 1 | 2016 | 339 | 0.120 |
Why?
|
Histone Deacetylase 2 | 1 | 2013 | 7 | 0.120 |
Why?
|
Systole | 1 | 2014 | 168 | 0.120 |
Why?
|
Estrogen Receptor beta | 1 | 2013 | 37 | 0.120 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2015 | 193 | 0.120 |
Why?
|
Physical Exertion | 1 | 2014 | 222 | 0.110 |
Why?
|
Aortic Valve Stenosis | 1 | 2017 | 295 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2015 | 420 | 0.110 |
Why?
|
Protein Biosynthesis | 1 | 2014 | 397 | 0.110 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2013 | 173 | 0.110 |
Why?
|
Transfection | 7 | 2015 | 888 | 0.110 |
Why?
|
Membrane Transport Proteins | 1 | 2013 | 136 | 0.110 |
Why?
|
Endoplasmic Reticulum | 1 | 2014 | 241 | 0.110 |
Why?
|
Endothelin-1 | 2 | 2011 | 168 | 0.100 |
Why?
|
Tumor Suppressor Proteins | 1 | 2014 | 289 | 0.100 |
Why?
|
Retroviridae Proteins, Oncogenic | 3 | 1997 | 12 | 0.100 |
Why?
|
Indoles | 1 | 2014 | 316 | 0.100 |
Why?
|
Adrenergic beta-1 Receptor Agonists | 1 | 2011 | 6 | 0.100 |
Why?
|
Azoles | 1 | 2011 | 6 | 0.100 |
Why?
|
Vascular Diseases | 1 | 2014 | 241 | 0.100 |
Why?
|
Cell Size | 2 | 2016 | 86 | 0.100 |
Why?
|
Receptors, Adrenergic, alpha-1 | 1 | 2011 | 40 | 0.100 |
Why?
|
Cats | 2 | 2022 | 205 | 0.100 |
Why?
|
2,2'-Dipyridyl | 1 | 2010 | 3 | 0.100 |
Why?
|
Recombinant Proteins | 6 | 2017 | 1308 | 0.090 |
Why?
|
Rats, Inbred Dahl | 3 | 2020 | 8 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2022 | 1945 | 0.090 |
Why?
|
Norepinephrine | 1 | 2011 | 212 | 0.090 |
Why?
|
Kinetics | 4 | 2006 | 1624 | 0.090 |
Why?
|
Heart Defects, Congenital | 1 | 2017 | 703 | 0.090 |
Why?
|
Saccharomyces cerevisiae | 3 | 2005 | 495 | 0.090 |
Why?
|
Estradiol | 1 | 2013 | 476 | 0.090 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 140 | 0.090 |
Why?
|
Consensus Sequence | 1 | 2010 | 70 | 0.090 |
Why?
|
Flow Cytometry | 1 | 2013 | 1085 | 0.090 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 332 | 0.090 |
Why?
|
Regional Blood Flow | 1 | 2012 | 418 | 0.090 |
Why?
|
Molecular Structure | 2 | 2011 | 459 | 0.090 |
Why?
|
Atrial Natriuretic Factor | 3 | 2004 | 59 | 0.090 |
Why?
|
Insulin Resistance | 1 | 2018 | 1180 | 0.090 |
Why?
|
Models, Animal | 1 | 2011 | 363 | 0.090 |
Why?
|
Immunoprecipitation | 1 | 2009 | 161 | 0.090 |
Why?
|
Embryo, Mammalian | 3 | 2020 | 220 | 0.090 |
Why?
|
Protein Interaction Mapping | 1 | 2010 | 104 | 0.090 |
Why?
|
Adult | 8 | 2019 | 31512 | 0.090 |
Why?
|
Cytokines | 2 | 2014 | 1900 | 0.090 |
Why?
|
Aniline Compounds | 1 | 2009 | 71 | 0.090 |
Why?
|
Precipitin Tests | 3 | 2004 | 93 | 0.080 |
Why?
|
Mutation | 5 | 2014 | 3457 | 0.080 |
Why?
|
Phenylephrine | 2 | 2021 | 85 | 0.080 |
Why?
|
Cell Survival | 3 | 2015 | 1047 | 0.080 |
Why?
|
NF-KappaB Inhibitor alpha | 5 | 2000 | 52 | 0.080 |
Why?
|
Cattle | 4 | 2013 | 978 | 0.080 |
Why?
|
Immunologic Factors | 1 | 2011 | 225 | 0.080 |
Why?
|
Cyclosporine | 2 | 1999 | 173 | 0.080 |
Why?
|
Muscle Fibers, Skeletal | 2 | 2020 | 192 | 0.080 |
Why?
|
Drug Design | 1 | 2009 | 160 | 0.080 |
Why?
|
Organ Culture Techniques | 2 | 2019 | 149 | 0.080 |
Why?
|
Piperazines | 1 | 2010 | 316 | 0.080 |
Why?
|
Swine | 2 | 2021 | 730 | 0.080 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2014 | 589 | 0.080 |
Why?
|
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2007 | 29 | 0.080 |
Why?
|
Proto-Oncogene Proteins | 3 | 1996 | 618 | 0.080 |
Why?
|
Muscle Fatigue | 1 | 2008 | 91 | 0.070 |
Why?
|
Diet | 1 | 2014 | 1153 | 0.070 |
Why?
|
Aged | 4 | 2018 | 19657 | 0.070 |
Why?
|
Aged, 80 and over | 1 | 2018 | 6561 | 0.070 |
Why?
|
Substrate Specificity | 2 | 2006 | 371 | 0.070 |
Why?
|
Neurons | 1 | 2015 | 1345 | 0.070 |
Why?
|
Rats, Inbred WF | 1 | 2006 | 5 | 0.070 |
Why?
|
Thiadiazoles | 1 | 2006 | 21 | 0.070 |
Why?
|
Neovascularization, Physiologic | 1 | 2008 | 181 | 0.070 |
Why?
|
Rats, Inbred SHR | 1 | 2006 | 42 | 0.070 |
Why?
|
Cocaine-Related Disorders | 1 | 2007 | 107 | 0.070 |
Why?
|
Biological Transport | 2 | 2013 | 382 | 0.070 |
Why?
|
Drug Delivery Systems | 1 | 2009 | 306 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2000 | 317 | 0.070 |
Why?
|
Inositol 1,4,5-Trisphosphate | 1 | 2006 | 27 | 0.070 |
Why?
|
Nuclear Envelope | 1 | 2006 | 21 | 0.070 |
Why?
|
Anilides | 1 | 2006 | 69 | 0.070 |
Why?
|
Phosphoproteins | 2 | 2001 | 308 | 0.070 |
Why?
|
Adenosine Diphosphate | 1 | 2006 | 88 | 0.070 |
Why?
|
Apoptosis | 4 | 2021 | 2484 | 0.070 |
Why?
|
MyoD Protein | 2 | 2002 | 28 | 0.070 |
Why?
|
Pneumonia | 1 | 2011 | 592 | 0.070 |
Why?
|
Models, Genetic | 3 | 2004 | 595 | 0.070 |
Why?
|
Gene Deletion | 3 | 2017 | 361 | 0.070 |
Why?
|
Protein Structure, Tertiary | 2 | 2008 | 823 | 0.070 |
Why?
|
Kidney Diseases | 1 | 2010 | 439 | 0.070 |
Why?
|
Models, Anatomic | 1 | 2006 | 94 | 0.070 |
Why?
|
Receptors, Cell Surface | 1 | 2007 | 367 | 0.070 |
Why?
|
Base Sequence | 6 | 2006 | 2159 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2008 | 527 | 0.060 |
Why?
|
Fluoresceins | 1 | 2004 | 47 | 0.060 |
Why?
|
Adhesins, Bacterial | 1 | 2004 | 36 | 0.060 |
Why?
|
Research Design | 2 | 2022 | 969 | 0.060 |
Why?
|
Metabolomics | 2 | 2019 | 550 | 0.060 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2015 | 136 | 0.060 |
Why?
|
Administration, Oral | 3 | 2011 | 756 | 0.060 |
Why?
|
Adenosine Triphosphate | 1 | 2006 | 439 | 0.060 |
Why?
|
Time Factors | 1 | 2014 | 6412 | 0.060 |
Why?
|
Real-Time Polymerase Chain Reaction | 2 | 2015 | 333 | 0.060 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2023 | 48 | 0.060 |
Why?
|
Interleukin-1beta | 2 | 2016 | 379 | 0.060 |
Why?
|
Action Potentials | 2 | 2017 | 420 | 0.060 |
Why?
|
Jurkat Cells | 2 | 2000 | 134 | 0.060 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2002 | 14 | 0.060 |
Why?
|
Carbamates | 1 | 2023 | 37 | 0.060 |
Why?
|
Green Fluorescent Proteins | 1 | 2004 | 395 | 0.060 |
Why?
|
Acetyltransferases | 1 | 2002 | 21 | 0.060 |
Why?
|
Tyrosine | 1 | 2023 | 233 | 0.060 |
Why?
|
Fluorescent Dyes | 1 | 2004 | 316 | 0.060 |
Why?
|
Cell Division | 2 | 2002 | 776 | 0.050 |
Why?
|
Sex Characteristics | 2 | 2019 | 671 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 827 | 0.050 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2023 | 407 | 0.050 |
Why?
|
Massachusetts | 1 | 2022 | 141 | 0.050 |
Why?
|
Mice, Obese | 1 | 2022 | 58 | 0.050 |
Why?
|
RNA, Small Nucleolar | 1 | 2021 | 8 | 0.050 |
Why?
|
Rats, Transgenic | 1 | 2021 | 14 | 0.050 |
Why?
|
Rats, Inbred BN | 1 | 2021 | 53 | 0.050 |
Why?
|
Gene Expression | 4 | 2016 | 1489 | 0.050 |
Why?
|
Swine, Miniature | 1 | 2021 | 71 | 0.050 |
Why?
|
American Heart Association | 1 | 2022 | 270 | 0.050 |
Why?
|
Culture Media | 1 | 2021 | 163 | 0.050 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2004 | 632 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2006 | 770 | 0.050 |
Why?
|
Cytoplasm | 3 | 2015 | 269 | 0.050 |
Why?
|
Blotting, Western | 2 | 2015 | 1194 | 0.050 |
Why?
|
DNA Primers | 3 | 1996 | 533 | 0.050 |
Why?
|
Peptides | 1 | 2006 | 879 | 0.050 |
Why?
|
Muscle Cells | 2 | 2010 | 42 | 0.050 |
Why?
|
Cell Death | 1 | 2002 | 339 | 0.050 |
Why?
|
Mutagenesis | 1 | 2000 | 176 | 0.050 |
Why?
|
Genes, ras | 1 | 2000 | 95 | 0.050 |
Why?
|
Genetic Engineering | 1 | 2000 | 83 | 0.050 |
Why?
|
Lung | 3 | 2020 | 3664 | 0.040 |
Why?
|
Serotonin | 2 | 2016 | 309 | 0.040 |
Why?
|
Stress, Psychological | 1 | 2007 | 972 | 0.040 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 187 | 0.040 |
Why?
|
Pregnancy | 2 | 2022 | 5690 | 0.040 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2019 | 10 | 0.040 |
Why?
|
Methylation | 1 | 2019 | 204 | 0.040 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2002 | 348 | 0.040 |
Why?
|
Coculture Techniques | 1 | 2019 | 208 | 0.040 |
Why?
|
Pharmacogenomic Testing | 1 | 2019 | 54 | 0.040 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 1999 | 107 | 0.040 |
Why?
|
RNA | 1 | 2004 | 833 | 0.040 |
Why?
|
Cyclic AMP | 1 | 2019 | 242 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2008 | 372 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2004 | 1284 | 0.040 |
Why?
|
Fatty Acids | 1 | 2021 | 407 | 0.040 |
Why?
|
Antigens, CD | 1 | 2000 | 460 | 0.040 |
Why?
|
Congresses as Topic | 1 | 2019 | 204 | 0.040 |
Why?
|
Fluorine Radioisotopes | 1 | 2017 | 11 | 0.040 |
Why?
|
Tissue Donors | 1 | 2019 | 336 | 0.040 |
Why?
|
Body Weight | 1 | 2022 | 934 | 0.040 |
Why?
|
Materials Testing | 1 | 2019 | 359 | 0.040 |
Why?
|
Autoradiography | 1 | 2017 | 72 | 0.040 |
Why?
|
Papio | 1 | 2017 | 92 | 0.040 |
Why?
|
Antihypertensive Agents | 2 | 2010 | 437 | 0.040 |
Why?
|
Enzyme Repression | 1 | 2016 | 8 | 0.040 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 3 | 2000 | 7 | 0.040 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2017 | 90 | 0.040 |
Why?
|
Protein Kinase C-epsilon | 1 | 2016 | 31 | 0.040 |
Why?
|
DNA Methylation | 1 | 2020 | 503 | 0.040 |
Why?
|
STAT1 Transcription Factor | 1 | 2016 | 69 | 0.040 |
Why?
|
Echocardiography | 1 | 2019 | 556 | 0.030 |
Why?
|
Multienzyme Complexes | 1 | 1996 | 64 | 0.030 |
Why?
|
Cysteine Endopeptidases | 1 | 1996 | 61 | 0.030 |
Why?
|
Interferon-beta | 1 | 2016 | 82 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2017 | 194 | 0.030 |
Why?
|
Metabolome | 1 | 2019 | 296 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 1996 | 139 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2019 | 642 | 0.030 |
Why?
|
Collagen Type III | 1 | 2015 | 20 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2017 | 239 | 0.030 |
Why?
|
Lymphocytes | 1 | 1997 | 347 | 0.030 |
Why?
|
Viral Proteins | 1 | 1997 | 296 | 0.030 |
Why?
|
Models, Molecular | 2 | 2010 | 1435 | 0.030 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 2014 | 13 | 0.030 |
Why?
|
Cardiomegaly, Exercise-Induced | 1 | 2014 | 3 | 0.030 |
Why?
|
Blood Sedimentation | 1 | 2014 | 34 | 0.030 |
Why?
|
Clathrin | 1 | 1995 | 31 | 0.030 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2014 | 23 | 0.030 |
Why?
|
Muscle Fibers, Slow-Twitch | 2 | 2008 | 13 | 0.030 |
Why?
|
T-Box Domain Proteins | 1 | 2015 | 95 | 0.030 |
Why?
|
Caseins | 1 | 2014 | 22 | 0.030 |
Why?
|
Acetyl-CoA Carboxylase | 1 | 2014 | 38 | 0.030 |
Why?
|
Trypanosoma cruzi | 1 | 2015 | 23 | 0.030 |
Why?
|
Soybean Proteins | 1 | 2014 | 22 | 0.030 |
Why?
|
Ketocholesterols | 1 | 2014 | 8 | 0.030 |
Why?
|
alpha-Crystallin B Chain | 1 | 2014 | 23 | 0.030 |
Why?
|
Ezetimibe | 1 | 2014 | 23 | 0.030 |
Why?
|
Azetidines | 1 | 2014 | 29 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2015 | 146 | 0.030 |
Why?
|
Gene Silencing | 1 | 2015 | 177 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2015 | 134 | 0.030 |
Why?
|
Microscopy, Electron | 1 | 2014 | 413 | 0.030 |
Why?
|
Primary Cell Culture | 1 | 2014 | 155 | 0.030 |
Why?
|
Apolipoproteins E | 1 | 2014 | 90 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 1597 | 0.030 |
Why?
|
Simvastatin | 1 | 2014 | 65 | 0.030 |
Why?
|
Mitochondria | 1 | 2020 | 786 | 0.030 |
Why?
|
Polypyrimidine Tract-Binding Protein | 1 | 2013 | 15 | 0.030 |
Why?
|
Actins | 1 | 2016 | 404 | 0.030 |
Why?
|
Isoquinolines | 1 | 2013 | 41 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 69 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 219 | 0.030 |
Why?
|
Blood-Retinal Barrier | 1 | 2013 | 14 | 0.030 |
Why?
|
Calmodulin | 2 | 2006 | 73 | 0.030 |
Why?
|
Liver | 1 | 2022 | 1816 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2014 | 178 | 0.030 |
Why?
|
Chemokine CCL2 | 1 | 2013 | 126 | 0.030 |
Why?
|
Receptor, Notch1 | 1 | 2013 | 65 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2013 | 109 | 0.030 |
Why?
|
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 44 | 0.030 |
Why?
|
Protein Kinase C-delta | 1 | 2013 | 69 | 0.030 |
Why?
|
Retroviridae | 1 | 1993 | 89 | 0.030 |
Why?
|
Familial Primary Pulmonary Hypertension | 1 | 2013 | 193 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2014 | 360 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2013 | 182 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2013 | 399 | 0.030 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2012 | 83 | 0.030 |
Why?
|
Sequence Alignment | 2 | 2004 | 336 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2015 | 1206 | 0.030 |
Why?
|
Oncogene Proteins v-rel | 3 | 1997 | 3 | 0.030 |
Why?
|
Genes, Reporter | 2 | 2004 | 270 | 0.030 |
Why?
|
Up-Regulation | 1 | 2015 | 872 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-rel | 3 | 1996 | 8 | 0.030 |
Why?
|
Connective Tissue | 1 | 2011 | 37 | 0.030 |
Why?
|
Chick Embryo | 3 | 1997 | 129 | 0.030 |
Why?
|
Aorta, Thoracic | 2 | 2007 | 248 | 0.030 |
Why?
|
ErbB Receptors | 1 | 1995 | 569 | 0.030 |
Why?
|
Kidney | 1 | 2019 | 1353 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 965 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 356 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2011 | 81 | 0.020 |
Why?
|
DNA, Viral | 1 | 1993 | 356 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 1995 | 551 | 0.020 |
Why?
|
Biological Availability | 1 | 2011 | 126 | 0.020 |
Why?
|
Retina | 1 | 2013 | 278 | 0.020 |
Why?
|
Atherosclerosis | 1 | 2014 | 345 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 410 | 0.020 |
Why?
|
Lipids | 1 | 2014 | 607 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 2 | 2004 | 653 | 0.020 |
Why?
|
MADS Domain Proteins | 1 | 2009 | 6 | 0.020 |
Why?
|
Neoplasms | 1 | 2004 | 2179 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2011 | 443 | 0.020 |
Why?
|
Colorado | 1 | 2019 | 4196 | 0.020 |
Why?
|
Sex Factors | 1 | 2014 | 1781 | 0.020 |
Why?
|
Monocytes | 1 | 2011 | 513 | 0.020 |
Why?
|
Phospholipase C gamma | 1 | 2008 | 25 | 0.020 |
Why?
|
Phosphoserine | 1 | 2008 | 34 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 2275 | 0.020 |
Why?
|
Protein Structure, Quaternary | 1 | 2008 | 116 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2008 | 86 | 0.020 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2007 | 53 | 0.020 |
Why?
|
Brain | 1 | 1999 | 2490 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2008 | 149 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2014 | 2674 | 0.020 |
Why?
|
Inositol 1,4,5-Trisphosphate Receptors | 1 | 2006 | 26 | 0.020 |
Why?
|
Nucleus Accumbens | 1 | 2007 | 131 | 0.020 |
Why?
|
United States | 1 | 2022 | 12555 | 0.020 |
Why?
|
Reward | 1 | 2007 | 209 | 0.020 |
Why?
|
Chickens | 1 | 2006 | 185 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2006 | 268 | 0.020 |
Why?
|
Cocaine | 1 | 2007 | 158 | 0.020 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2006 | 101 | 0.020 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2004 | 12 | 0.020 |
Why?
|
Calcium Channels | 1 | 2006 | 150 | 0.020 |
Why?
|
Receptors, Steroid | 1 | 2004 | 54 | 0.020 |
Why?
|
DNA | 2 | 2003 | 1388 | 0.020 |
Why?
|
Rabbits | 1 | 2006 | 780 | 0.020 |
Why?
|
Infant | 1 | 2017 | 8293 | 0.010 |
Why?
|
Thymus Gland | 1 | 2004 | 300 | 0.010 |
Why?
|
Tritium | 1 | 2003 | 70 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2003 | 55 | 0.010 |
Why?
|
Ventricular Myosins | 1 | 2003 | 33 | 0.010 |
Why?
|
Emotions | 1 | 2007 | 495 | 0.010 |
Why?
|
Leucine | 1 | 2003 | 117 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2008 | 732 | 0.010 |
Why?
|
Glycogen Synthase Kinases | 1 | 2002 | 3 | 0.010 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2002 | 83 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2004 | 770 | 0.010 |
Why?
|
Isoproterenol | 1 | 2002 | 125 | 0.010 |
Why?
|
Chronic Disease | 1 | 2007 | 1636 | 0.010 |
Why?
|
Two-Hybrid System Techniques | 1 | 2001 | 58 | 0.010 |
Why?
|
Young Adult | 1 | 2016 | 10793 | 0.010 |
Why?
|
Thyroid Hormones | 1 | 2000 | 55 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2001 | 201 | 0.010 |
Why?
|
Muscle Fibers, Fast-Twitch | 1 | 2000 | 15 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2001 | 200 | 0.010 |
Why?
|
Alcohol Oxidoreductases | 1 | 2001 | 57 | 0.010 |
Why?
|
Luciferases | 1 | 2000 | 143 | 0.010 |
Why?
|
Exons | 1 | 2000 | 307 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2000 | 136 | 0.010 |
Why?
|
Expressed Sequence Tags | 1 | 1999 | 38 | 0.010 |
Why?
|
Organ Specificity | 1 | 2000 | 278 | 0.010 |
Why?
|
Electric Stimulation | 1 | 2000 | 268 | 0.010 |
Why?
|
Zinc Fingers | 1 | 1999 | 46 | 0.010 |
Why?
|
Ligation | 1 | 1999 | 82 | 0.010 |
Why?
|
Aorta, Abdominal | 1 | 1999 | 40 | 0.010 |
Why?
|
Fetus | 1 | 2003 | 690 | 0.010 |
Why?
|
Adolescent | 1 | 2017 | 18480 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1999 | 311 | 0.010 |
Why?
|
Testis | 1 | 1999 | 144 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1999 | 334 | 0.010 |
Why?
|
Mice, Nude | 1 | 2000 | 663 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1999 | 546 | 0.010 |
Why?
|
Motor Neurons | 1 | 2000 | 213 | 0.010 |
Why?
|
Child | 1 | 2017 | 19129 | 0.010 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 1997 | 44 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 1999 | 331 | 0.010 |
Why?
|
Proto-Oncogenes | 1 | 1996 | 27 | 0.010 |
Why?
|
Aorta | 1 | 1999 | 367 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1996 | 76 | 0.010 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1996 | 139 | 0.010 |
Why?
|
src Homology Domains | 1 | 1996 | 34 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 1999 | 755 | 0.010 |
Why?
|
Gene Products, tax | 1 | 1995 | 9 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2000 | 531 | 0.010 |
Why?
|
Transcription Factor RelA | 1 | 1995 | 82 | 0.010 |
Why?
|
3T3 Cells | 1 | 1995 | 141 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 1996 | 874 | 0.010 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 1995 | 48 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1995 | 363 | 0.010 |
Why?
|
Databases, Factual | 1 | 1999 | 1231 | 0.010 |
Why?
|
Transcription Factor RelB | 1 | 1993 | 4 | 0.010 |
Why?
|
Cell Transformation, Viral | 1 | 1993 | 22 | 0.010 |
Why?
|
Antibodies | 1 | 1995 | 392 | 0.010 |
Why?
|
Birds | 1 | 1993 | 81 | 0.010 |
Why?
|
Peptide Fragments | 1 | 1996 | 702 | 0.010 |
Why?
|
Spleen | 1 | 1993 | 510 | 0.010 |
Why?
|
HIV-1 | 1 | 1995 | 776 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 1993 | 1167 | 0.000 |
Why?
|